Your browser doesn't support javascript.
loading
[Relationship between maintenance dosages of fluindione (Préviscan) and warfarin (Coumadin) for patients 70 years and older]. / Nomogramme d'équivalence entre les posologies de fluindione (Préviscan) et de warfarine (Coumadine) pour des patients de 70 ans et plus.
Pautas, É; Peyron, I; Gouin-Thibault, I; Gouronnec, A; Monti, A; Bouhadiba, S; Badie, C; Golmard, J-L; Siguret, V.
Afiliação
  • Pautas É; Service de court séjour gériatrique, hôpital Charles-Foix, groupe hospitalier Pitié-Salpêtrière Charles-Foix (AP-HP), 7, avenue de la République, 94205 Ivry-sur-Seine, France; UFR Pierre-et-Marie-Curie, université Paris 6, 75013 Paris, France; Inserm UMR-S-765, université Paris Descartes, Sorbonne P
  • Peyron I; Pharmacie, hôpital Charles-Foix, groupe hospitalier Pitié-Salpêtrière Charles-Foix (AP-HP), 94205 Ivry-sur-Seine, France.
  • Gouin-Thibault I; Inserm UMR-S-765, université Paris Descartes, Sorbonne Paris-Cité, 75006 Paris, France; Service d'hématologie biologique, hôpital Cochin (AP-HP), 75005 Paris, France.
  • Gouronnec A; Service de court séjour gériatrique, hôpital Charles-Foix, groupe hospitalier Pitié-Salpêtrière Charles-Foix (AP-HP), 7, avenue de la République, 94205 Ivry-sur-Seine, France.
  • Monti A; Service de court séjour gériatrique, hôpital Charles-Foix, groupe hospitalier Pitié-Salpêtrière Charles-Foix (AP-HP), 7, avenue de la République, 94205 Ivry-sur-Seine, France.
  • Bouhadiba S; Laboratoire d'hématologie, hôpital Charles-Foix, groupe hospitalier Pitié-Salpêtrière Charles-Foix (AP-HP), 94205 Ivry-sur-Seine, France.
  • Badie C; Laboratoire d'hématologie, hôpital Charles-Foix, groupe hospitalier Pitié-Salpêtrière Charles-Foix (AP-HP), 94205 Ivry-sur-Seine, France.
  • Golmard JL; Département de biostatistiques, groupe hospitalier Pitié-Salpêtrière Charles-Foix (AP-HP), 75013 Paris, France.
  • Siguret V; Inserm UMR-S-765, université Paris Descartes, Sorbonne Paris-Cité, 75006 Paris, France; Service d'hématologie biologique, hôpital européen Georges-Pompidou (AP-HP), 75015 Paris, France.
Rev Med Interne ; 36(1): 7-9, 2015 Jan.
Article em Fr | MEDLINE | ID: mdl-24373728
ABSTRACT

INTRODUCTION:

Switching from fluindione, an indanedione vitamin K antagonist derivative, to warfarin, a coumarin one, or vice versa, requires to know the relationships between dosages of these two molecules.

METHODS:

We conducted a prospective study in 288 consecutive patients aged 70 years and over, converted from fluindione to warfarin. Patients who were retained for the analysis were those for whom maintenance dosages were obtained for both vitamin K antagonists.

RESULTS:

Eighty-two patients, mean aged 83 ± 6 years, were analysed. The average daily maintenance dosages were 13.8 ± 6.7 mg (range 5-35) and 3.7 ± 1.7 mg (range 1-8) for fluindione and warfarin, respectively. Using a linear regression model, we built a transition algorithm for the maintenance dosages of warfarin and fluindione.

CONCLUSION:

This is the first study to propose a conversion algorithm to help prescribers to estimate the maintenance dosage when it is necessary for a patient to switch from fluindione to warfarin or conversely.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenindiona / Trombose / Varfarina / Nomogramas / Cálculos da Dosagem de Medicamento / Anticoagulantes Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: Fr Revista: Rev Med Interne Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenindiona / Trombose / Varfarina / Nomogramas / Cálculos da Dosagem de Medicamento / Anticoagulantes Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: Fr Revista: Rev Med Interne Ano de publicação: 2015 Tipo de documento: Article